Hołubowicz, Rafał
Du, Samuel W. https://orcid.org/0000-0002-9655-3659
Felgner, Jiin
Smidak, Roman
Choi, Elliot H.
Palczewska, Grazyna
Menezes, Carolline Rodrigues
Dong, Zhiqian https://orcid.org/0000-0002-8748-4532
Gao, Fangyuan
Medani, Omar
Yan, Alexander L. https://orcid.org/0000-0002-8594-7994
Hołubowicz, Maria W.
Chen, Paul Z.
Bassetto, Marco
Risaliti, Eleonora
Salom, David https://orcid.org/0000-0002-3208-1509
Workman, J. Noah https://orcid.org/0000-0002-0921-1803
Kiser, Philip D. https://orcid.org/0000-0003-1184-9539
Foik, Andrzej T. https://orcid.org/0000-0003-1110-9223
Lyon, David C.
Newby, Gregory A.
Liu, David R. https://orcid.org/0000-0002-9943-7557
Felgner, Philip L. https://orcid.org/0000-0002-4117-8505
Palczewski, Krzysztof https://orcid.org/0000-0002-0788-545X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01EY009339, R01EY030873, P30EY034070, P30CA062203, T32GM008620, F30EY033642, P30EY034070, T32GM148383, R01EY032948, R21NS113264, R00HL163805, UG3AI150551, U01AI142756, R35GM118062, RM1HG009490, 75N93022C00054)
Knights Templar Eye Foundation
U.S. Department of Veterans Affairs (I01BX004939)
Narodowe Centrum Nauki (2022/47/B/NZ5/03023, 2020/39/D/NZ4/01881, 2019/34/E/NZ5/00434)
Fundacja na rzecz Nauki Polskiej (FENG.02.01-IP.05-T005/23)
Howard Hughes Medical Institute
United States Department of Defense | Defense Threat Reduction Agency (N66001-21-C-4013)
Article History
Received: 19 December 2023
Accepted: 25 October 2024
First Online: 28 November 2024
Competing interests
: K.P. is a consultant for Polgenix Inc. and AbbVie Inc. and serves on the Scientific Advisory Board of Hyperion Eye Ltd. D.R.L. is a consultant and/or equity owner for Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine and Nvelop Therapeutics, companies that use or deliver genome-editing or epigenome-engineering agents. G.A.N. and D.R.L. have filed patent applications on other genome editing technologies through the Broad Institute. The other authors declare no competing interests.